High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life

References

• Mangelli L, Fava GA, Grandi S, et al. Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry 2005;66:391–4.
   PubMed Web of Science ®Google Scholar
• Robinson S, Kissane DW, Brooker J, Burney S. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manage 2015;49:595–610.
   PubMed Web of Science ®Google Scholar
• Frank JD. Psychotherapy: the restoration of morale. Am J Psychiatry 1974;131:271–4.
   PubMed Web of Science ®Google Scholar
• Thornicroft G, Slade M. New trends in assessing the outcomes of mental health interventions. World Psychiatry 2014;13:118–24.
   PubMed Web of Science ®Google Scholar
• Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329–33.
   PubMed Web of Science ®Google Scholar
• King MC, Marks JH, Mandell JB, Group NYBCS. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643–6.
   PubMed Web of Science ®Google Scholar
• Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117–30.
   PubMed Web of Science ®Google Scholar
• Heemskerk-Gerritsen BA, Menke-Pluijmers MB, Jager A, et al. Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis. Ann Oncol 2013;24:2029–35.
   PubMed Web of Science ®Google Scholar
• Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004;22:1055–62.
   PubMed Web of Science ®Google Scholar
• Hermsen BB, Olivier RI, Verheijen RH, et al. No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer 2007;96:1335–42.
   PubMed Web of Science ®Google Scholar
• Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80–7.
   PubMed Web of Science ®Google Scholar
• Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967–75.
   PubMed Web of Science ®Google Scholar
• Finch AP, Lubinski J, Moller P, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 2014;32:1547–53.
   PubMed Web of Science ®Google Scholar
• Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 2006;296:185–92.
   PubMed Web of Science ®Google Scholar
• Dowdy SC, Stefanek M, Hartmann LC. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol 2004;191:1113–23.
   PubMed Web of Science ®Google Scholar
• Challberg J, Ashcroft L, Lalloo F, et al. Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT. Br J Cancer 2011;105:22–7.
   PubMed Web of Science ®Google Scholar
• Madalinska JB, van Beurden M, Bleiker EM, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 2006;24:3576–82.
   PubMed Web of Science ®Google Scholar
• Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause (New York, NY) 2006;13:265–79.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Maraganore DM. The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener Dis 2008;5:257–60.
   PubMed Web of Science ®Google Scholar
• Svejme O, Ahlborg HG, Nilsson JA, Karlsson MK. Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women. BJOG 2012;119:810–16.
   PubMed Web of Science ®Google Scholar
• Finch A, Metcalfe KA, Chiang JK, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 2011;121:163–8.
   PubMed Web of Science ®Google Scholar
• Finch A, Metcalfe KA, Chiang J, et al. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation. Psychooncology 2013;22:212–19.
   PubMed Web of Science ®Google Scholar
• Fang CY, Cherry C, Devarajan K, et al. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 2009;112:594–600.
   PubMed Web of Science ®Google Scholar
• Brandberg Y, Sandelin K, Erikson S, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 2008;26:3943–9.
   PubMed Web of Science ®Google Scholar
• Gopie JP, Mureau MA, Seynaeve C, et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer 2013;12:479–87.
   PubMed Web of Science ®Google Scholar
• den Heijer M, Seynaeve C, Timman R, et al. Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer 2012;48:1263–8.
   PubMed Web of Science ®Google Scholar
• Bresser PJ, Van Gool AR, Seynaeve C, et al. Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy? Ann Oncol 2007;18:1641–5.
   PubMed Web of Science ®Google Scholar
• Bresser PJ, Seynaeve C, Van Gool AR, et al. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 2007;43:95–103.
   PubMed Web of Science ®Google Scholar
• Cohen SR, Mount BM, Tomas JJ, Mount LF. Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer 1996;77:576–86.
   PubMed Web of Science ®Google Scholar
• Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry 2002;36:733–42.
   PubMed Web of Science ®Google Scholar
• Kissane DW, Wein S, Love A, et al. The Demoralization Scale: a report of its development and preliminary validation. J Palliat Care 2004;20:269–76.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000;284:2907–11.
   PubMed Web of Science ®Google Scholar
• Watson M, Haviland JS, Greer S, et al. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999;354:1331–6.
   PubMed Web of Science ®Google Scholar
• Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer 2005;41:1710–14.
   PubMed Web of Science ®Google Scholar
• Vehling S, Mehnert A. Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model. Psychooncology 2014;23:283–90.
   PubMed Web of Science ®Google Scholar
• de Figueiredo JM. Depression and demoralization: phenomenologic differences and research perspectives. Compr Psychiatry 1993;34:308–11.
   PubMed Web of Science ®Google Scholar
• Griffith JL, Gaby L. Brief psychotherapy at the bedside: countering demoralization from medical illness. Psychosomatics 2005;46:109–16.
   PubMed Web of Science ®Google Scholar
• Clarke DM, Chapter 7. Depression, demoralization, and psychotherapy in people who are medically ill. In: Alarcon RD, Frank JB, eds. The psychotherapy of hope: the legacy of persuasion and healing. Baltimore: Johns Hopkins University Press; 2012.
   Google Scholar
• De Jong CAJ, Kisanne DW, Geessink RJ, van der Velden D. Demoralization in opioid dependent patients: a comparative study with cancer patients and community subjects. Open Addict J 2008;1:7–9.
   Google Scholar
• Vehling S, Lehmann C, Oechsle K, et al. Is advanced cancer associated with demoralization and lower global meaning? The role of tumor stage and physical problems in explaining existential distress in cancer patients. Psychooncology 2012;21:54–63.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussel: European Organisation for Research and Treatment of Cancer; 2001.
   Google Scholar
• Spielberger CD, Lushene RE, Jacobs GA, Manual for the State-Trait Anxiety Inventory, STAI (Form Y). Palo Alto (CA): Consulting Psychologists Press; 1983.
   Google Scholar
• van der Ploeg HM. Self-assessment Questionnaire (STAI-DY) – development and validation of Dutch questionnaire to measure anxiety. Tijdschrift Voor Psychiatrie 1982;24:576–88.
   Google Scholar
• Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843–50.
   PubMed Web of Science ®Google Scholar
• Watson M, Duvivier V, Wade Walsh M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998;35:731–8.
   PubMed Web of Science ®Google Scholar
• Douma KFL, Aaronson NK, Vasen HFA, et al. Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology 2010;19:289–98.
   PubMed Web of Science ®Google Scholar
• Custers JA, van den Berg SW, van Laarhoven HW, et al. The cancer worry scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 2014;37:E44–50.
   PubMed Web of Science ®Google Scholar
• Fava GA, Mangelli L, Ruini C. Assessment of psychological distress in the setting of medical disease. Psychother Psychosom 2001;70:171–5.
   PubMed Web of Science ®Google Scholar
• Rafanelli C, Roncuzzi R, Milaneschi Y, et al. Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Psychother Psychosom 2005;74:179–84.
   PubMed Web of Science ®Google Scholar
• Grassi L, Sabato S, Rossi E, et al. Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom 2005;74:100–7.
   PubMed Web of Science ®Google Scholar
• Grandi S, Sirri L, Tossani E, Fava GA. Psychological characterization of demoralization in the setting of heart transplantation. J Clin Psychiatry 2011;72:648–54.
   PubMed Web of Science ®Google Scholar
• Porcelli P, De Carne M, Todarello O. Prediction of treatment outcome of patients with functional gastrointestinal disorders by the diagnostic criteria for psychosomatic research. Psychother Psychosom 2004;73:166–73.
   PubMed Web of Science ®Google Scholar
• Sonino N, Navarrini C, Ruini C, et al. Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004;73:78–83.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. and American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association, 2013.
   Google Scholar
• Vehling S, Oechsle K, Koch U, Mehnert A. Receiving palliative treatment moderates the effect of age and gender on demoralization in patients with cancer. PLoS One 2013;8:e59417.
   PubMed Web of Science ®Google Scholar
• Touboul C, Uzan C, Ichante JL, et al. Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancer. Oncologist 2011;16:1250–7.
   PubMed Web of Science ®Google Scholar
• Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890–8.
   PubMed Web of Science ®Google Scholar
• Robson M, Hensley M, Barakat R, et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 2003;89:281–7.
   PubMed Web of Science ®Google Scholar
• Elit L, Esplen MJ, Butler K, Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer 2001;1:149–56.
   PubMedGoogle Scholar
• Breitbart W, Rosenfeld B, Pessin H, et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol 2015;33:749–54.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Poppito S, Rosenfeld B, et al. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol 2012;30:1304–9.
   PubMed Web of Science ®Google Scholar
• Lethborg C, Schofield P, Kissane D. The advanced cancer patient experience of undertaking meaning and purpose (MaP) therapy. Palliat Support Care 2012;10:177–88.
   PubMed Web of Science ®Google Scholar
• van der Spek N, Vos J, van Uden-Kraan CF, et al. Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial. BMC Psychiatry 2014;14:22.
   PubMed Web of Science ®Google Scholar
• Clarke DM, Mackinnon AJ, Smith GC, et al. Dimensions of psychopathology in the medically ill. A latent trait analysis. Psychosomatics 2000;41:418–25.
   PubMed Web of Science ®Google Scholar
• Clarke DM, Smith GC, Dowe DL, McKenzie DP. An empirically derived taxonomy of common distress syndromes in the medically ill. J Psychosom Res 2003;54:323–30.
   PubMed Web of Science ®Google Scholar
• Clarke DM, Kissane DW, Trauer T, Smith GC. Demoralization, anhedonia and grief in patients with severe physical illness. World Psychiatry 2005;4:96–105.
   PubMedGoogle Scholar